Saturday, July 11, 2026

Drug profile · INN

tiratricol

tiratricol (EMCITATE) is a thyroid hormone receptor agonist.

EMA: approved Systemic hormonal preparations (H03) H03AA04
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — tiratricol
Class
Systemic hormonal preparations (H03)
Route
Patents
0
Programs
4
Data quality
0.83

Quick answer

tiratricol (EMCITATE) is a thyroid hormone receptor agonist.

Key facts

INN tiratricol
Brand EMCITATE
Mechanism Thyroid hormone receptor agonist
Target Thyroid hormone receptor
Therapeutic class Systemic hormonal preparations (H03)
ATC code H03AA04

Mechanism of action

Thyroid hormone receptor agonist

Primary target: Thyroid hormone receptor

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. MCT8-2021-3 Phase 3 · Rare Thyroid Therapeutics · Monocarboxylate Transporter 8 (MCT8) deficiency
  2. Tiratricol Phase 3 · Ultragenyx UK · Monocarboxylate Transporter 8 Deficiency
  3. Tiratricol Phase 2 · Ultragenyx UK · Allan-Herndon-Dudley Syndrome
  4. Tiratricol, Tiratricol Phase 2 · Rare Thyroid Therapeutics · Monocarboxylate Transporter 8 (MCT8) deficiency

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Frequently asked questions

What is tiratricol?

tiratricol (EMCITATE) is a thyroid hormone receptor agonist.

What is the brand name for tiratricol?

EMCITATE is a marketed brand name for tiratricol. Check FDA Drugs@FDA for the current US label holder and prescribing information.